Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5)

Saved in:
Bibliographic Details
Main Authors: Schuler, Esther (Author) , Nolte, Florian (Author)
Format: Article (Journal) Editorial
Language:English
Published: 26 January 2016
In: Leukemia
Year: 2016, Volume: 30, Issue: 7, Pages: 1580-1582
ISSN:1476-5551
DOI:10.1038/leu.2015.340
Online Access:Verlag, Volltext: https://doi.org/10.1038/leu.2015.340
Verlag, Volltext: https://www.nature.com/articles/leu2015340
Get full text
Author Notes:E. Schuler, A. Giagounidis, D. Haase, K. Shirneshan, G. Büsche, U. Platzbecker, F. Nolte, K. Götze, R.F. Schlenk, A. Ganser, A. Letsch, F. Braulke, M. Lübbert, G. Bug, P. Schafhausen, U. Bacher, N. Gattermann, M. Wulfert, R. Haas and U. Germing

MARC

LEADER 00000caa a2200000 c 4500
001 1668957159
003 DE-627
005 20220816190800.0
007 cr uuu---uuuuu
008 190710s2016 xx |||||o 00| ||eng c
024 7 |a 10.1038/leu.2015.340  |2 doi 
035 |a (DE-627)1668957159 
035 |a (DE-599)KXP1668957159 
035 |a (OCoLC)1341233343 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schuler, Esther  |e VerfasserIn  |0 (DE-588)1190254069  |0 (DE-627)1668956101  |4 aut 
245 1 0 |a Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5)  |c E. Schuler, A. Giagounidis, D. Haase, K. Shirneshan, G. Büsche, U. Platzbecker, F. Nolte, K. Götze, R.F. Schlenk, A. Ganser, A. Letsch, F. Braulke, M. Lübbert, G. Bug, P. Schafhausen, U. Bacher, N. Gattermann, M. Wulfert, R. Haas and U. Germing 
264 1 |c 26 January 2016 
300 |a 3 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 10.07.2019 
700 1 |a Nolte, Florian  |d 1976-  |e VerfasserIn  |0 (DE-588)1033390348  |0 (DE-627)741150433  |0 (DE-576)380987031  |4 aut 
773 0 8 |i Enthalten in  |t Leukemia  |d London : Springer Nature, 1997  |g 30(2016), 7, Seite 1580-1582  |h Online-Ressource  |w (DE-627)32046699X  |w (DE-600)2008023-2  |w (DE-576)094139733  |x 1476-5551  |7 nnas  |a Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5) 
773 1 8 |g volume:30  |g year:2016  |g number:7  |g pages:1580-1582  |g extent:3  |a Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5) 
856 4 0 |u https://doi.org/10.1038/leu.2015.340  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/leu2015340  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20190710 
993 |a Editorial 
994 |a 2016 
998 |g 1033390348  |a Nolte, Florian  |m 1033390348:Nolte, Florian  |d 60000  |d 61200  |e 60000PN1033390348  |e 61200PN1033390348  |k 0/60000/  |k 1/60000/61200/  |p 7 
999 |a KXP-PPN1668957159  |e 3492527817 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["32046699X"],"zdb":["2008023-2"],"issn":["1476-5551"]},"origin":[{"publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke","publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group","dateIssuedKey":"1997","dateIssuedDisp":"1997-"}],"language":["eng"],"recId":"32046699X","note":["Gesehen am 15.03.04"],"disp":"Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5)Leukemia","type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"extent":"3","text":"30(2016), 7, Seite 1580-1582","volume":"30","pages":"1580-1582","issue":"7","year":"2016"},"pubHistory":["Nachgewiesen 11.1997 -"],"title":[{"title_sort":"Leukemia","subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal","title":"Leukemia"}]}],"physDesc":[{"extent":"3 S."}],"name":{"displayForm":["E. Schuler, A. Giagounidis, D. Haase, K. Shirneshan, G. Büsche, U. Platzbecker, F. Nolte, K. Götze, R.F. Schlenk, A. Ganser, A. Letsch, F. Braulke, M. Lübbert, G. Bug, P. Schafhausen, U. Bacher, N. Gattermann, M. Wulfert, R. Haas and U. Germing"]},"id":{"eki":["1668957159"],"doi":["10.1038/leu.2015.340"]},"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"26 January 2016"}],"language":["eng"],"recId":"1668957159","type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 10.07.2019"],"person":[{"display":"Schuler, Esther","roleDisplay":"VerfasserIn","role":"aut","family":"Schuler","given":"Esther"},{"given":"Florian","family":"Nolte","role":"aut","display":"Nolte, Florian","roleDisplay":"VerfasserIn"}],"title":[{"title":"Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5)","title_sort":"Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5)"}]} 
SRT |a SCHULERESTRESULTSOFA2620